BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection

Yao Chen,Ryan A. Zander,Xiaopeng Wu,David M. Schauder,Moujtaba Y. Kasmani,Jian Shen,Shikan Zheng,Robert Burns,Elizabeth J. Taparowsky,Weiguo Cui
DOI: https://doi.org/10.1038/s41590-021-00965-7
IF: 30.5
2021-07-19
Nature Immunology
Abstract:During chronic viral infection, CD8<sup>+</sup> T cells develop into three major phenotypically and functionally distinct subsets: Ly108<sup>+</sup>TCF-1<sup>+</sup> progenitors, Ly108<sup>−</sup>CX<sub>3</sub>CR1<sup>−</sup> terminally exhausted cells and the recently identified CX<sub>3</sub>CR1<sup>+</sup> cytotoxic effector cells. Nevertheless, how CX<sub>3</sub>CR1<sup>+</sup> effector cell differentiation is transcriptionally and epigenetically regulated remains elusive. Here, we identify distinct gene regulatory networks and epigenetic landscapes underpinning the formation of these subsets. Notably, our data demonstrate that CX<sub>3</sub>CR1<sup>+</sup> effector cells bear a striking similarity to short-lived effector cells during acute infection. Genetic deletion of <i>Tbx21</i> significantly diminished formation of the CX<sub>3</sub>CR1<sup>+</sup> subset. Importantly, we further identify a previously unappreciated role for the transcription factor BATF in maintaining a permissive chromatin structure that allows the transition from TCF-1<sup>+</sup> progenitors to CX<sub>3</sub>CR1<sup>+</sup> effector cells. BATF directly bound to regulatory regions near <i>Tbx21</i> and <i>Klf2</i>, modulating their enhancer accessibility to facilitate the transition. These mechanistic insights can potentially be harnessed to overcome T cell exhaustion during chronic infection and cancer.
immunology
What problem does this paper attempt to address?